FHC
IHE icon

First Heartland Consultants’s iShares US Pharmaceuticals ETF IHE Stock Holding History

First Heartland Consultants’s Portfolio IHE Stock Details IHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-1,092
Closed -$36K – 288
2013
Q2 		$36K Buy
+1,092
New +$36.3K 0.02% 282

Other funds holding IHE

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
BCI
Brinker Capital Investments Berwyn, Pennsylvania $13.1B AUM 28.37% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
SFI
SPC Financial Inc Rockville, Maryland $1.28B AUM 12.6% 1-Year Est. Return
MCM
Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

First Heartland Consultants's IHE Position: Q3 2013 in Review

First Heartland Consultants sold out of iShares US Pharmaceuticals ETF (IHE) in Q3 2013, closing a stake of 1,092 shares — an estimated $36K sold.

First Heartland Consultants first reported a position in IHE in Q2 2013 and held it in 1 quarter. The position peaked at $36K in Q2 2013. 63 funds tracked by Wall St. Rank hold IHE as of Q3 2013.

  • First Heartland Consultants reported no remaining iShares US Pharmaceuticals ETF position as of Q3 2013 after selling out during the quarter.
  • First Heartland Consultants sold 1,092 iShares US Pharmaceuticals ETF shares in Q3 2013, an estimated $36K.
  • First Heartland Consultants first reported a position in iShares US Pharmaceuticals ETF in Q2 2013 and held it in 1 quarter.
  • First Heartland Consultants's iShares US Pharmaceuticals ETF position peaked at $36K in Q2 2013.
  • 63 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q3 2013.

Based on First Heartland Consultants's 13F filing for Q3 2013, filed 14 Nov 2013.